SynthesisBriefings in bioinformatics2026
Deep representation learning for temporal inference in cancer omics: a systematic literature review.
Synthesis in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Deep learning methods, including deep representation learning (DRL) approaches such as variational autoencoders (VAEs), have been widely applied to cancer omics data to address the high dimensionality of these datasets. Despite remarkable advances, cancer is a complex and dynamic disease, making it challenging to study, and the temporal resolution of cancer progression captured by omics-based studies remains limited. In this systematic literature review, we explore the use of DRL, particularly the VAE, in cancer omics studies for modeling time-related processes, such as tumor progression and evolutionary dynamics. Our work reveals that these methods most commonly support subtyping, diagnosis, and prognosis in this context, but rarely emphasize temporal information. We observed that the scarcity of longitudinal omics data currently limits deeper temporal analyses that could enhance these applications. We propose that applying the VAE as a generative model to study cancer in time, particularly focusing on cancer staging, could lead to meaningful advancements in our understanding of the disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.